Specific Aldosterone Synthase Inhibition: A Potential Improvement Over Mineralocorticoid Receptor Antagonism?

被引：0
作者：
Schneider, Markus P. [1 ]
Hilgers, Karl F. [1 ]
机构：
[1] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany
来源：
HYPERTENSION | 2017年 / 69卷 / 01期
关键词：
DOUBLE-BLIND; HYPERTENSION; DEOXYCORTICOSTERONE; PLACEBO; DISEASE; TRIAL;
D O I：
10.1161/HYPERTENSIONAHA.116.07939
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 11 条
  • [1] Aldosterone Synthase Inhibition With LCI699 A Proof-of-Concept Study in Patients With Primary Aldosteronism
    Amar, Laurence
    Azizi, Michel
    Menard, Joel
    Peyrard, Severine
    Watson, Catherine
    Plouin, Pierre-Francois
    [J]. HYPERTENSION, 2010, 56 (05) : 831 - +
  • [2] Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2)
    Bogman, Katrijn
    Schwab, Dietmar
    Delporte, Marie-Laure
    Palermo, Giuseppe
    Amrein, Kurt
    Mohr, Susanne
    Mudry, Maria Cristina De Vera
    Brown, Morris J.
    Ferber, Philippe
    [J]. HYPERTENSION, 2017, 69 (01) : 189 - 196
  • [3] Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial
    Calhoun, David A.
    White, William B.
    Krum, Henry
    Guo, Weinong
    Bermann, Georgina
    Trapani, Angelo
    Lefkowitz, Martin P.
    Menard, Joel
    [J]. CIRCULATION, 2011, 124 (18) : 1945 - U124
  • [4] Mineralocorticoid Receptors, Salt-Sensitive Hypertension, and Metabolic Syndrome
    Fujita, Toshiro
    [J]. HYPERTENSION, 2010, 55 (04) : 813 - 818
  • [5] The role of aldosterone and mineralocorticoid receptors in cardiovascular disease
    Funder, John W.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2007, 7 (03) : 151 - 157
  • [6] Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
    Matsumoto, Yoshihiro
    Mori, Yasuo
    Kageyama, Shinji
    Arihara, Kazuo
    Sugiyama, Toshikazu
    Ohmura, Hiromichi
    Yakushigawa, Toru
    Sugiyama, Hatsumi
    Shimada, Yasushi
    Nojima, Youichi
    Shio, Nobuo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (06) : 529 - 536
  • [7] Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects
    Menard, Joel
    Rigel, Dean F.
    Watson, Catherine
    Jeng, Arco Y.
    Fu, Fumin
    Beil, Michael
    Liu, Jing
    Chen, Wei
    Hu, Chii-Whei
    Leung-Chu, Jennifer
    LaSala, Daniel
    Liang, Guiqing
    Rebello, Sam
    Zhang, Yiming
    Dole, William P.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [8] Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues
    Sharma, KK
    Lindqvist, A
    Zhou, XJ
    Auchus, RJ
    Penning, TM
    Andersson, S
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 248 (1-2) : 79 - 86
  • [9] The mislabelling of deoxycorticosterone: making sense of corticosteroid structure and function
    Vinson, Gavin P.
    [J]. JOURNAL OF ENDOCRINOLOGY, 2011, 211 (01) : 3 - 16
  • [10] 24 HOUR PATTERN OF EPISODIC SECRETION OF CORTISOL IN NORMAL SUBJECTS
    WEITZMAN, ED
    FUKUSHIMA, D
    NOGEIRE, C
    ROFFWARG, H
    GALLAGHER, TF
    HELLMAN, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1971, 33 (01) : 14 - +
12